HomeNDC LookupRxCUI directory › RxCUI 1726271

Ixabepilone 45 MG Injection — RxCUI 1726271

RxNorm drug concept · Semantic clinical drug
RxCUI 1726271 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1726271
Official nameIxabepilone 45 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ixabepilone Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • IXEMPRA is specifically designed for situations where breast cancer has stopped responding to earlier treatments like anthracyclines, taxanes, or capecitabine. It works through a d...
  • Why am I getting this drug if I've already tried other chemotherapy?
  • IXEMPRA contains an ingredient called Cremophor EL that can trigger allergic reactions in some people — even serious ones. Taking an H1 and H2 antihistamine about an hour before ea...
  • Why do I have to take antihistamines before every infusion?
📖 Read our full Ixabepilone Injection guide →

🕸️ Concept Web — How Ixabepilone 45 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ixabepilone 45 MG Injection RxCUI 1726271

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ixabepilone 337523
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • IXEMPRA 744825
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ixabepilone Injection 1726270
    • Ixabepilone Injectable Product 1161945
    • Ixabepilone Injection [IXEMPRA] 1726273
    • IXEMPRA Injectable Product 1166568
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ixabepilone 45 MG SCDC · 1726269
  • Ixabepilone Injection SCDF · 1726270
  • Ixabepilone Injectable Product SCDG · 1161945

Brand-Name Concepts

  • Ixabepilone 45 MG Injection [IXEMPRA] SBD · 1726274
  • Ixabepilone 45 MG [IXEMPRA] SBDC · 1726272
  • Ixabepilone Injection [IXEMPRA] SBDF · 1726273
  • IXEMPRA Injectable Product SBDG · 1166568
  • IXEMPRA BN · 744825

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1726271 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70020-1910-01 1 KIT in 1 PACKAGE, COMBINATION (70020-1910-1) * 15 mg in... IXEMPRA R-Pharm US Operating, LLC 2007-10-16
70020-1911-01 1 KIT in 1 PACKAGE, COMBINATION (70020-1911-1) * 45 mg in... IXEMPRA R-Pharm US Operating, LLC 2007-10-16
Observed labelers: R-Pharm US Operating, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9207 Ixabepilone injection 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.